Log in
Enquire now
‌

US Patent 7098308 Pentapeptide compounds and uses related thereto

Patent 7098308 was granted and assigned to Seagen on August, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Seagen
Seagen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
70983080
Patent Inventor Names
Brian E. Toki0
Peter D. Senter0
Svetlana Doronina0
Date of Patent
August 29, 2006
0
Patent Application Number
109799230
Date Filed
November 1, 2004
0
Patent Citations Received
‌
US Patent 11788066 Antibody conjugates and methods of making and using the same
‌
US Patent 12016842 Methods of using anti-CD79b immunoconjugates
0
‌
US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use
0
Patent Primary Examiner
‌
David Lukton
0
Patent abstract

Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieities, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7098308 Pentapeptide compounds and uses related thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.